By Reuters | New Delhi |
Topics Coronavirus Vaccine | Pfizer | Vaccine
Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.
Pfizer and German partner BioNTech SE are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine.
Following are reactions to the news. WALID GELLAD, PROFESSOR OF MEDICINE, UNIVERSITY OF PITTSBURGH, UNITED STATES "This is a hint that these mRNA vaccines are likely to work, and there's.
This article is no longer available in our repository.
There could be multiple reasons for this.
You could try searching for this headline on the source website (bloomberg.com).